We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Americold
COLD
$4.17B
| $15.9M | 0.02% |
743,223
-558,720
| -43% | -$12.1M |
|
552
Fortive
FTV
$18.6B
| $15.9M | 0.02% |
289,066
-55,971
| -16% | -$3.29M |
|
553
Keysight
KEYS
$60.6B
| $15.5M | 0.02% |
103,584
-3,116
| -3% | -$514K |
|
554
Constellation Brands
STZ
$22.9B
| $15.5M | 0.02% |
84,331
+1,583
| +2% | +$288K |
|
555
ResMed
RMD
$32.8B
| $15.4M | 0.02% |
68,922
-384
| -0.6% | -$89.6K |
|
556
Dover
DOV
$28B
| $15.4M | 0.02% |
87,773
+872
| +1% | +$168K |
|
557
Corning
GLW
$144B
| $15.4M | 0.02% |
336,414
-13,073
| -4% | -$646K |
|
558
Guardant Health
GH
$22.2B
| $15.4M | 0.02% |
356,670
-236,846
| -40% | -$10.2M |
|
|
GRFS
559
Grifois
GRFS
$5.4B
| $15.3M | 0.02% |
2,140,357
-486,246
| -19% | -$3.67M |
|
|
SOBO
560
South Bow Corp
SOBO
$7.64B
| $15.3M | 0.02% |
598,192
+892
| +0.1% | +$22.3K |
|
561
Eversource Energy
ES
$26.9B
| $15.2M | 0.02% |
245,248
-52,293
| -18% | -$3.12M |
|
562
LPL Financial
LPLA
$29.7B
| $15.2M | 0.02% |
46,536
-1,434
| -3% | -$499K |
|
563
F5
FFIV
$24B
| $15.1M | 0.02% |
56,754
-8,142
| -13% | -$2.28M |
|
564
PPG Industries
PPG
$25.5B
| $15M | 0.02% |
137,384
-2,670
| -2% | -$308K |
|
|
HES
565
DELISTED
Hess
HES
| $14.8M | 0.02% |
92,790
-12,546
| -12% | -$1.84M |
|
566
Darden Restaurants
DRI
$25.9B
| $14.8M | 0.02% |
71,150
-663
| -0.9% | -$128K |
|
567
Celsius Holdings
CELH
$6.99B
| $14.8M | 0.02% |
414,299
+393,117
| +1,856% | +$10.7M |
|
568
Medpace
MEDP
$16.7B
| $14.5M | 0.02% |
46,549
-7,035
| -13% | -$2.37M |
|
569
Stevanato
STVN
$5.8B
| $14.5M | 0.02% |
710,208
-5,511
| -0.8% | -$117K |
|
|
HOLX
570
DELISTED
Hologic
HOLX
| $14.3M | 0.02% |
232,093
-74,056
| -24% | -$4.91M |
|
571
Protagonist Therapeutics
PTGX
$9.84B
| $14.3M | 0.02% |
295,593
-918
| -0.3% | -$38.5K |
|
572
Neogen
NEOG
$2.5B
| $14.2M | 0.02% |
1,636,635
-732,960
| -31% | -$7.68M |
|
573
Northern Trust
NTRS
$35B
| $14.1M | 0.02% |
143,127
+8,919
| +7% | +$947K |
|
574
Sabesp
SBS
$17.9B
| $14M | 0.02% |
4,052,052
+473,467
| +13% | +$1.51M |
|
575
Nucor
NUE
$61.9B
| $13.9M | 0.02% |
115,683
-15,690
| -12% | -$2.02M |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.